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Abstract
As the seventh leading cause of death in the United States, diabetes affects 29.1
million people. In May, 2015 the U.S. CDC reported, the estimated total financial
burden for diabetes in the United States at greater than $245 billion ($69 billion
attributed to disability, lost days at work and premature death). The purpose of this
study was to investigate genetic variances in parallel with type II diabetes. Through a
five year prior search of Cochrane, Medline and Pubmed this review of the literature
examined studies regarding type II diabetes related genetic variances specific to nonethnic and ethnic populations of otherwise healthy adults aged 18-65 years old.
Methods encompassed extracting DNA from nuclear pellets. Further genotyping was
conducted using SNPlex or Assays on Demand. A p value of less than 0.05 was
considered statistically significant. Literature reviews utilized centre-stratified
analyses, combining evidence from each centre using fixed-effect meta-analyses. The
authors then assessed research subjects against controls utilizing measured
genotype and additive genetic models adjusted for age and gender. Significance
thresholds were then adjusted where a p value of < 0.05 was considered statistically
significant. Franceschini et al. (2013), Wu et al. (2014) Hanson et al. (2013), Kato
(2013), Yagootak and Frayling (2013), Sun, Yu and Hu (2014) and Pal and McCarthy
(2013) stated over 60 genetic loci have been identified to date in candidate gene and
genome-wide association studies regarding type II diabetes. Of the genetic loci
discovered, Wu et al. (2014) and Yagatook and Frayling (2013) determined variants at
TCF7L2 resemble the most robust correlation with type II diabetes. Wu et al. (2014)
found a 96% concordance rate among monozygotic twins with type II diabetes, as
well as a 40% incidence rate of developing type II diabetes among those who have
first-degree relatives with the disease. However, Kato (2013) suggests previous studies
only account for 5-10% of heritability associated with type II diabetes. Sun, Yu and
Hu (2014) reported the concept of pharmacogenomics (drug molecular mechanisms
related to gene variants and drug efficacy) may eventually drive clinical decision
making regarding type II diabetes drug selection, dose titration and adverse side
effect avoidance. Based on the results of the studies in this review, accurate genetic
data reveals potential to evolve clinically into a valuable instrument, thereby
facilitating optimized therapeutics and deferring or suspending the onset of type II
diabetes.

Introduction
The global epidemic of type II diabetes has proven to exist as one of the greatest
clinically perplexing diseases of the twenty first century. Considerable evidence
suggests type II diabetes is a multifactorial disease with robust genetically related
components. According to Sanghera and Blackett (2012), recent genome-wide
association studies have effectively recognized and replicated between 60-75
susceptibility loci correlated with type II diabetes and interrelated metabolic traits.
Genome wide association studies function as an introduction to forthcoming genetic
and functional research, considering the specific mechanisms by which type II
diabetes linked genes sway disease remains uncertain. Further lending to problematic
implication of current genetic discoveries into clinical environments. Conversely,
evidence has progressively exposed novel underlying type II diabetes molecular
pathways, etiology, gene-environment interactions, epigenetic modifications, and
gene function. Although large scale, time-consuming and painstaking genome wide
association studies have successfully identified common risk alleles correlated with
type II diabetes with sufficient statistical power, these studies should further consider
how the information gained can ultimately be converted into early intervention and
prediction of type II diabetes (Kato 2013).

Research Question
What genetic factors are responsible for the increasing incidence of type II diabetes
among adults?

Discussion
•

Wu et al. (2014) conducted research that resulted in genetic loci related to
hyperglycemia progression to type II diabetes.

•

Franceschini et al. (2013) conducted research that resulted in genetic loci in
proximity to genes which affect pancreatic beta cell development.

•

Kato (2013) conducted research resulting in the discovery of type II diabetes genes
located in intergenetic regions.

•

Wu et al. (2014) conducted research resulting in type II diabetes concordance rates
among twins and first-degree relatives.

•

Hanson et al. (2013) conducted a study resulting in inherited type II diabetes genes
in Native American people.

•

Su, Yu and Hu (2014) conducted research resulting in the utility of a concept
known as pharmacogenomics.

•

Pal and McCarthy (2013) conducted research resulting in clinical application of
type II diabetes genetic data.

Literature Review
• According to Franceschini et al. (2013) and Wu et al. (2014) evidence to date
suggests there exists a utility regarding genetic evaluation of glycaemic
deterioration from hyperglycemia to type II diabetes.
• Franceschini et al. (2013), Wu et al. (2014) Hanson et al. (2013), Kato (2013),
Yagootak and Frayling (2013), Sun, Yu and Hu (2014) and Pal and McCarthy (2013)
all concur that over 60 genetic loci have been identified in candidate gene and
genome-wide association studies regarding type II diabetes.
• Franceschini et al. (2013) propose several of the 60 identified loci are located in or
near-by genes affecting pancreatic beta cell development and function, related to
insulin secretion.
• Kato (2013) suggests KLF14 is more commonly is found in Europeans with type II
diabetes, however not in East and South Asians. (See Figure 1.)
• Kato (2013) suggests some gene variant loci are not in fact neighboring observable
candidate genes, however are often located in areas known as intergenetic regions.
(See Figure 2.)

Applicability to Clinical
Practice
• With more than 70 genetic loci identified that correlate to type II diabetes
susceptibility, further investigation and narrowing of these novel findings is
advised by those within the research community.
• Although several genetic variants have been identified and further studied for
prediction value of type II diabetes, these genetic variants only marginally
improved prediction beyond noninvasive characteristics in previous studies.
• Specific genetic loci such as KNCJ11 and PPARG2 serve as therapeutic targets for
specific antihyperglycemic agents such as sulfonylurea and thiazolidinedione
classes of medications.
• Research suggests variations of multiple gene loci are correlated with clinical
variation in oral antidiabetic drug tolerance, effect, glycemic response and
tolerance by individual patients.

• Hanson et al. (2013) suggest there exists a strong parent-of-origin effect within
recently identified gene single nucleotide polymorphisms which confirm
susceptibility to type II diabetes among Native American people.
• Kato (2013) suggests previous studies only account for 5-10% of heritability
associated with type II diabetes, through factors such as insufficient surveys of rare
variants, inaccuracy of current heritability estimates and epigenetics.
• Wu et al. (2014) and Yagatook and Frayling (2013) agree, of the genetic loci
discovered, variants at TCF7L2 resemble the most robust correlation with type II
diabetes.

References

• Su, Yu and Hu (2014) propose the aim of pharmacogenomics is to explore molecular
mechanisms of type II diabetes therapeutics as they relate to specific gene variants.
• Pal and McCarthy (2013) concur with Su Yu and Hu (2014), stating if major
discoveries into type II diabetes pathogenesis are discovered, these unique
mechanisms potentially give rise to enriched treatment outcomes.
• Wu et al. (2014) suggests type II diabetes susceptibility loci exhibit a polygenic
phenomenon where heritability is subsequently determined by a large number of
genes, each having a nominal mass effect.

Statement of the Problem
According to the Centers for Disease Control, diabetes is the 7th leading cause of
death in the United States. Enhanced predictive, preventative and therapeutic
methodologies are warranted to defray morbidity and mortality from this debilitating
and deadly disease.

• Yaghootak and Frayling (2013) suggest evidence from prior studies reveals a direct
yet sometimes paradoxical relationship between genetic variants and metabolic
traits known to be in close relationship to type II diabetes risk.

Figure 1. Risk Allele Frequency.
Risk allele frequencies and effect sizes of known susceptibility
loci for type II diabetes , which have shown significant (P ≤ 5 ×
10−8) association. Identified in populations of European
descent, some were exclusively found or first reported in
non‐European populations (Kato 2013).

Figure 2. Intertrait Overlap

• Wu et al. (2014) proposes a 96% concordance rate among monozygotic twins with
type II diabetes, as well as a 40% incidence rate of developing type II diabetes
among those who have first-degree relatives with the disease.

• Hanson et al. (2013) hypothesize; the population variances in genetic risk scores
between Native Americans, East Asians and Africans could represent alterations
presentative of genetic drift or natural selection.

Figure 1. Risk Allele Frequency.

Figure 2. Intertrait Overlap
Intertrait difference (or overlapping) for 41 diabetes‐related trait
associated loci that have been reported in meta‐analyses of
genome‐wide association studies. The traits include fasting plasma
glucose (FPG), insulin and its related‐traits (homeostasis model
assessment of β‐cell function (HOMA‐B) and HOMA of insulin
resistance), and glycated hemoglobin (HbA1c). Here, an associated locus
is assumed to overlap between the traits when P ≤ 5 × 10−8 was
concordantly attained. Underlined are the loci that have shown
significant (P ≤ 5 × 10−8) association with type 2 diabetes; at three loci
with asterisks – ANK1,CDKAL1 and GRB14 – variants associated with
individual traits are not in linkage disequilibrium (r2 < 0.3) (Kato 2013).
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